Media

In a new white paper issued today, BIO updates the results of a study of the greenhouse gas emissions resulting from EPA's proposal to reduce biofuel use...
BIO is pleased to announce the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology to be presented to an outstanding...

Press Releases

Jun 22 2000
WASHINGTON, D.C. (June 22, 2000) --TheBiotechnology Industry Organization (BIO) has named Missouri Gov. Mel Carnahan Governor of the Year for his support of...
Jun 20 2000
WASHINGTON, D.C. (June 20, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on an...
Jun 13 2000
WASHINGTON, D.C. (June 13, 2000) - Paul Abrams, CEO of NeoRx Corp., testified today on behalf of the Biotechnology Industry Organization (BIO) at a U.S. Senate...
Jun 5 2000
WASHINGTON (June 5, 2000) - Results of a study publishedtoday indicate that earlier laboratory reports of a relationship between mortality of butterflies and...
May 24 2000
(Michael J. Werner, Director of Federal Government Relations/Bioethics Counsel for the Biotechnology Industry Organization (BIO), issued the following...
May 17 2000
WASHINGTON, D.C. and OAKLAND, Calif., May 17, 2000 The Biotechnology Industry Organization (BIO) and DoubleTwist Inc. today announced they signed a letter of...
May 15 2000
WASHINGTON, D.C., (May 15, 2000) - BIO anticipatesrecord-breaking attendance at its Legislative Day here Tuesday and Wednesday, May 16 - 17, with about 150...
May 12 2000
WASHINGTON, D.C. (May 12, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a Maine...
May 3 2000
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding FDA Commissioner Jane Henney’s...


Biotechnology News

October 22, 2014

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next...

October 22, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 2014 Credit Suisse Healthcare Conference on Wednesday,...

October 22, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced it has completed its acquisition of Civitas Therapeutics and obtained global...

October 22, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the closing of its underwritten public offering of 4,542,500 shares of...

October 22, 2014

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (12:30 p.m. GMT) on Wednesday, Oct. 29, 2014, to discuss the company’s...